Aarti Surfactants has reappointed its top leadership team and expanded its board with a new independent director, signaling continuity in its strategic direction.

The company’s Board of Directors, meeting on August 22, 2026, approved the reappointment of Mr. Nikhil P. Desai as CEO & Managing Director and Mr. Santosh M. Kakade as Executive Director. Both appointments are for a five-year term effective from August 20, 2027, pending shareholder approval at the ensuing Annual General Meeting (AGM).

Leadership Continuity

Mr. Desai, who brings over 20 years of experience across IT, project management, and technical sales, will not be liable to retire by rotation. His father, Mr. Parimal H. Desai, serves as a Non-Executive Director and Promoter of the company.

Mr. Kakade, with more than three decades of experience in plant operations and process development, will be liable to retire by rotation. He is not related to any other director on the board.

New Independent Director

The board also appointed Prof. Vandana B. Patravale as an Additional Director in the category of Non-Executive Independent Director. Her five-year term begins immediately from August 22, 2026, subject to shareholder approval at the AGM.

Prof. Patravale holds a Ph.D. in Pharmaceutics and is a Senior Professor at the Institute of Chemical Technology (ICT), Mumbai. With over 35 years of academic and research experience, her expertise includes cosmetology, regulatory affairs, and advanced pharmaceutics. She has contributed significantly to novel nanocarrier development for cosmeceuticals and applications in malaria, cancer, and neurodegenerative disorders.

Operational Changes

In other developments, the board approved an alteration to the Main Object Clause of the Memorandum of Association to broaden the scope of the company’s activities. This change requires shareholder approval at the AGM.

Additionally, Mrs. Kanika Rathore was promoted from Vice President – Business & Operations to President – Business & Operations, effective August 22, 2026.

The company confirmed that all appointees are not debarred from holding office by SEBI or any other regulatory authority. The disclosures were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Aarti Surfactants Limited reported a sharp acceleration in profitability for the quarter ended June 30, 2026, as standalone net profit surged 197% year-on-year to ₹9.08 crore. The chemical ingredients manufacturer posted consolidated net profit of ₹9.00 crore, up 206% from ₹2.94 crore in the corresponding period of FY25. This strong bottom-line performance was underpinned by a 26% rise in revenue from operations to ₹272.87 crore, reflecting robust demand in its home and personal care ingredients segment.

The Board of Directors approved the unaudited standalone and consolidated financial results on August 1, 2026. The results were reviewed by the Audit Committee and subjected to limited review by statutory auditors Gokhale & Sathe Chartered Accountants. The company disclosed compliance with Regulations 30, 33, and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On August 3, 2026, the company submitted newspaper clippings of the results published in Financial Express (English) and Naidunia (Hindi) on August 2, 2026, in accordance with Regulation 47 of the SEBI LODR Regulations.

Financial Performance

Revenue from operations stood at ₹27,287.01 lakh for the quarter, compared to ₹21,589.92 lakh in Q1FY25. Total income remained consistent at ₹27,303.85 lakh. On the expense side, cost of materials consumed increased to ₹22,919.52 lakh from ₹18,775.75 lakh, while employee benefits and finance costs saw marginal increases. Operating margin expanded significantly to 7.49% from 5.41% in the prior year period, indicating improved operational efficiency despite higher input costs.

Consolidated figures mirrored this trend, with revenue at ₹27,287.01 lakh and net profit attributable to owners of the company at ₹900.08 lakh. Basic EPS for the consolidated entity rose to ₹10.63 from ₹3.48 in the previous year.

Key Ratios and Balance Sheet Signals

The company’s debt equity ratio improved slightly to 0.49 from 0.47 in Q1FY25, indicating stable leverage levels. The debt service coverage ratio strengthened substantially to 3.61 from 1.19, enhancing financial flexibility. Interest service coverage ratio also climbed to 5.81 from 3.57. Current ratio moderated to 1.23 from 1.34, while inventory turnover ratio improved to 1.89 from 1.36, suggesting better stock management efficiency.

What the Numbers Show

The most notable shift in Q1FY26 is the divergence between revenue growth and margin expansion. While revenue grew 26%, operating margins expanded by over 200 basis points to 7.49%. This suggests that Aarti Surfactants successfully passed on higher input costs or benefited from favorable product mix shifts. The nearly doubling of the debt service coverage ratio further indicates that the top-line growth has translated into significantly stronger cash flow generation relative to debt obligations, reducing near-term refinancing risks.